Home > Insider Trading > Filing (0001062993-22-007055)

Filing Details

Accession Number:: 0001062993-22-007055
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-08 15:05:58
Reporting Period:: 2022-03-08

Accepted Time:: 2022-03-08 15:05:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1707925	Linde Plc	LIN	Industrial Inorganic Chemicals (2810)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1757274	Sanjiv Lamba	C/O Linde Plc The Priestley Centre, 10 Priestley Road Guildford, Surrey X0 GU2 7XY	Chief Executive Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2022-03-08	3,750	$268.62	33,690	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Restricted Stock Units	$0.00			3,895	3,895	Direct
Ordinary Shares	Restricted Stock Units	$0.00			3,090	3,090	Direct
Ordinary Shares	Restricted Stock Units	$0.00			3,590	3,590	Direct
Ordinary Shares	Stock Option (right to buy)	$253.68	2022-03-08	2031-03-08	40,995	40,995	Direct
Ordinary Shares	Stock Option (right to buy)	$173.13	2021-03-09	2030-03-09	37,565	37,565	Direct
Ordinary Shares	Stock Option (right to buy)	$1.92	2021-06-07	2022-06-07	2,840	2,840	Direct
Ordinary Shares	Stock Option (right to buy)	$176.63	2020-03-20	2029-03-20	40,470	40,470	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	3,895	3,895	Direct
	3,090	3,090	Direct
	3,590	3,590	Direct
2031-03-08	40,995	40,995	Direct
2030-03-09	37,565	37,565	Direct
2022-06-07	2,840	2,840	Direct
2029-03-20	40,470	40,470	Direct

Footnotes

The price reported is the weighted average purchase price. The per share purchase prices ranged from $268.54 to $269.27. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price
Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one basis.
This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.
This option vests over three years in three consecutive equal annual installments beginning March 20, 2020.